Oxandrolone
- Generic Name
- Oxandrolone
- Brand Names
- Oxandrin
- Drug Type
- Small Molecule
- Chemical Formula
- C19H30O3
- CAS Number
- 53-39-4
- Unique Ingredient Identifier
- 7H6TM3CT4L
Overview
A synthetic hormone with anabolic and androgenic properties.
Background
A synthetic hormone with anabolic and androgenic properties.
Indication
Use to promote weight gain after weight loss following extensive surgery.
Associated Conditions
- Amino acid catabolism disorder
- Pain
Clinical Trials
FDA Approved Products
Oxandrolone
Manufacturer:Par Pharmaceutical, Inc.
Route:ORAL
Strength:10 mg in 1 1
Approved: 2023/07/05
NDC:49884-302
Oxandrolone
Manufacturer:Par Pharmaceutical, Inc.
Route:ORAL
Strength:2.5 mg in 1 1
Approved: 2023/07/05
NDC:49884-301
Oxandrolone
Manufacturer:Upsher-Smith Laboratories, LLC
Route:ORAL
Strength:2.5 mg in 1 1
Approved: 2020/07/01
NDC:0245-0271
oxandrolone
Manufacturer:Upsher-Smith Laboratories, LLC
Route:ORAL
Strength:10 mg in 1 1
Approved: 2020/07/01
NDC:0245-0272
Oxandrolone
Manufacturer:Bryant Ranch Prepack
Route:ORAL
Strength:2.5 mg in 1 1
Approved: 2022/05/06
NDC:63629-7603
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath